Stephanie J. (Nahas) Nahas-Geiger MD
Headache
Associate Professor, Neurology, Thomas Jefferson University
Join to View Full Profile
900 Walnut StSte 200Philadelphia, PA 19107
Phone+1 215-955-2243
Fax+1 215-955-2060
Dr. Nahas-Geiger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephanie Nahas is a neurologist with subspecialty certification in headache medicine practicing in Philadelphia, PA. She is affiliated with Thomas Jefferson University Hospitals. She received her medical degree from Rush Medical College in 2001, completed neurology residency in 2005, followed by fellowship in headache medicine, and has been on faculty at Jefferson since January 2007. She is active in teaching (UME/GME/CME) and advocacy in addition to her clinical and research endeavors.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Headache Medicine, 2005 - 2007- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 2002 - 2005
Rush University Medical CenterInternship, Internal Medicine, 2001 - 2002
Rush Medical College of Rush University Medical CenterClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
PA State Medical License 2002 - 2026
American Board of Psychiatry and Neurology Neurology
United Council of Neurologic SubspecialtiesHeadache Medicine
Awards, Honors, & Recognition
- Fellow American Headache Society
- Fellow American Academy of Neurology
Publications & Presentations
PubMed
- Reaching international consensus on the definition of refractory migraine using the Delphi method.Jennifer Robblee, Fawad A Khan, Michael J Marmura, Hope L O'Brien, Lawrence D Robbins
Cephalalgia. 2025-09-01 - Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete-choice experiment.Richard B Lipton, Pranav Gandhi, Kelley Myers, Cooper Bussberg, Jonathan Stokes
Headache. 2025-06-24 - 1 citationsCost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine.Jessica Ailani, Pranav Gandhi, Anjana Lalla, Rashmi Halker Singh, Peter McAllister
Headache. 2024-09-09
Press Mentions
Q&A: Dr. Nahas Discusses Migraine Prevention TherapyAugust 20th, 2025- Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine TreatmentJune 19th, 2025
- Targeting CGRP for Acute Migraine ReliefMarch 31st, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
